Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis

Treatment of diffuse subretinal fibrosis uveitis with rituximab

(2014) Kurt Spiteri Cornish et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry

(2012) M. E. ZANNIN et al.   JOURNAL OF RHEUMATOLOGY

Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated with Juvenile Idiopathic Arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study

(2012) Anthony C. Gregory et al.   OPHTHALMOLOGY

Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases

(2011) E. Miserocchi et al.   AUTOIMMUNITY REVIEWS

Rituximab for Uveitis

(2011) Elisabetta Miserocchi et al.   OPHTHALMOLOGY

Rituximab in Refractory Ophthalmic Wegener's Granulomatosis

(2011) Lavnish Joshi et al.   OPHTHALMOLOGY

Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab)

(2011) A. Heiligenhaus et al.   RHEUMATOLOGY

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis

(2009) Michael G. Barnes et al.   ARTHRITIS AND RHEUMATISM

Epidemiology and Course of Disease in Childhood Uveitis

(2009) Janine A. Smith et al.   OPHTHALMOLOGY

Focus on adverse events of tumour necrosis factor   blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients

(2007) V Gerloni et al.   ANNALS OF THE RHEUMATIC DISEASES